Live Breaking News & Updates on Judith Mcgarry

Stay updated with breaking news from Judith mcgarry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial

SEATTLE & CAMBRIDGE, Mass. & TOKYO, March 28, 2024 Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has dosed the first Canadian subject in its Phase 1 / 2 clinical trial (ABA-1, CLARA) of AURN001, a cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction. ....

United Kingdom , United States , Michele Gray , Judith Mcgarry , Michael Goldstein , Prix Galien , Beth Keshishian , Allogeneic Cell Therapy , Corneal Edema Secondary , Corneal Endothelial , Aurion Biotech , Chief Medical Officer , Flyingl Partners , Falcon Vision ,

Greg Kunst, CEO of Aurion Biotech, Receives Healthcare Leadership Award from Puget Sound Business Journal

Greg Kunst, CEO of Aurion Biotech, Receives Healthcare Leadership Award from Puget Sound Business Journal
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Michele Gray , Greg Kunst , Judith Mcgarry , Prix Galien , Beth Keshishian , Shigeru Kinoshita , Kyoto Prefecture University Of Medicine , Healthcare Leadership , Puget Sound Business Journal , Puget Sound , Aurion Biotech , Professor Shigeru Kinoshita , Kyoto Prefecture University , Flyingl Partners , Falcon Vision ,